Age at onset determines severity and choice of treatment in early rheumatoid arthritis: a prospective study

Table 2 Age in relation to disease-modifying antirheumatic drug treatment within 3 months after disease onset ^a

Covariates	OR	95% CI	P-value
Age at disease onset^b	0.403	0.217 to 0.749	<0.01
Female sex	1.002	0.535 to 1.878	0.994
ACPA-positive	1.484	0.812 to 2.712	0.199
ESR (T0), mm/h	1.027	1.009 to 1.045	<0.01

^aACPA, Anticyclic citrullinated peptide/protein; CI: Confidence interval; DMARD, Disease-modifying antirheumatic drug; ESR, Erythrocyte sedimentation rate; OR: Odds ratio. ^bAge at disease onset classified as young-onset rheumatoid arthritis <58 years old and late-onset rheumatoid arthritis ≥58 years old. Data are derived from multiple logistic regression (n = 562).

ISSN: 1478-6362